Clinical Trial Update: Radiotherapy As an Immunological Booster in Patients with Metastatic Melanoma or Renal Cell Carcinoma Treated with High-dose Interleukin-2 [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating radiotherapy as an immunological booster in patients with metastatic melanoma or metastatic renal cell carcinoma treated with high-dose…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma
• Renal Cell Carcinoma

Drugs mentioned

• Interleukin-2 (interleukin-2)

Snippet

Sponsor: Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS | Conditions: Metastatic Renal Cell Cancer, Malignant Melanoma, Metastatic | Phase 2 | Status: COMPLETED